Dr... Show more
The 10-day moving average for RDY crossed bullishly above the 50-day moving average on December 22, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 22, 2025. You may want to consider a long position or call options on RDY as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for RDY just turned positive on December 19, 2025. Looking at past instances where RDY's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
RDY moved above its 50-day moving average on December 19, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RDY advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 254 cases where RDY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 50 cases where RDY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The 50-day moving average for RDY moved below the 200-day moving average on December 02, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RDY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.942) is normal, around the industry mean (21.577). P/E Ratio (18.022) is within average values for comparable stocks, (74.473). Projected Growth (PEG Ratio) (3.793) is also within normal values, averaging (1.981). RDY has a moderately low Dividend Yield (0.007) as compared to the industry average of (0.030). P/S Ratio (3.087) is also within normal values, averaging (64.586).
a developer of pharmaceuticals
Industry PharmaceuticalsGeneric
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| TSMG | 26.37 | 0.62 | +2.39% |
| Leverage Shares 2X Long Tsm Daily ETF | |||
| JDVI | 36.19 | 0.15 | +0.41% |
| JHancock Discp Val Intl Sel ETF | |||
| PPH | 104.43 | 0.13 | +0.13% |
| VanEck Pharmaceutical ETF | |||
| GAID | 25.41 | N/A | N/A |
| Guinness Atkinson Intl Div Bldr ETF | |||
| PALC | 53.13 | -0.01 | -0.02% |
| Pacer Lunt Large Cap Mlt Ftr Alt ETF | |||
A.I.dvisor tells us that RDY and COLL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RDY and COLL's prices will move in lockstep.
| Ticker / NAME | Correlation To RDY | 1D Price Change % | ||
|---|---|---|---|---|
| RDY | 100% | +0.50% | ||
| COLL - RDY | 31% Poorly correlated | +0.52% | ||
| VTRS - RDY | 28% Poorly correlated | +0.65% | ||
| KMDA - RDY | 27% Poorly correlated | -0.28% | ||
| HROW - RDY | 27% Poorly correlated | -0.14% | ||
| TAK - RDY | 27% Poorly correlated | +0.45% | ||
More | ||||
| Ticker / NAME | Correlation To RDY | 1D Price Change % |
|---|---|---|
| RDY | 100% | +0.50% |
| Pharmaceuticals: Generic industry (212 stocks) | 27% Poorly correlated | +0.10% |